[ET Net News Agency, 15 September 2025] HSBC kept the target price for Sinopharm (01099) at HKD18 and maintained the "hold" rating.
The research house said it lowers 2025-27e EPS estimates by 6% on continued gross margin pressure. (rc)
The research house said it lowers 2025-27e EPS estimates by 6% on continued gross margin pressure. (rc)